What benefits will the health basket give?

People who contracted benign tumors in their jaws and need rehabilitation will get it at state cost.

January 4, 2017 01:22
1 minute read.

Pills. (photo credit: INGIMAGE / ASAP)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Some of the medical technologies in the health basket will benefit over 21,000 people (screening tests for Smith-Lemli- Opitz, a genetic disease in Ashkenazi Jews), while three will help 11 patients, including a twomonth- old baby suffering from short-bowel syndrome and rare metabolic diseases. Two other screening tests will look for an estimated 500 carriers of a genetic disease found in Jews of Bukharan origin, and another will check for genetic disorders found in about 930 Arabs and Druse.

Fully half of the basket will go to treat cancers. NIS 40 million will be allocated to expand free basic dental care at health fund clinics to age 15. Patients with non-squamous lung cancer will be able to get a new immunotherapy drug. Duodopa, a drug for Parkinson’s disease, was added for epilepsy patients who have not benefited from other drugs.

Hearing aids for adults aged 31 to 50 who were not previously eligible will now be provided.

People who contracted benign tumors in their jaws and need rehabilitation will get it at state cost, as will women who froze ovarian tissue for becoming pregnant after chemotherapy for cancer that would have destroyed the tissue.

Drugs for cardiovascular diseases include Multaq, Coralan and Entrestro. For dermatology they are Picato gel, Otexia and Humira. For type-2 diabetes they include Forxiga and Jardiance (but only for 34,570 patients who have certain indications). For hemato-oncology they are Venclexta, Bosulif, Opdiva, Difolta, Empliciti, Darzalex and Ninlaro.

For lung hypertension they include Viagra and Cialis, and for liver diseases, a number of new drugs will replace less effective ones at no extra cost.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

May 23, 2019
Regenerative medicine firm CollPlant launches Israel R&D center